Suppr超能文献

核因子-κB前体p105和原癌基因产物Bcl-3是IκB分子,并控制核因子-κB的核转位。

The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.

作者信息

Naumann M, Wulczyn F G, Scheidereit C

机构信息

Max-Planck-Institut für Molekulare Genetik, Otto-Warburg-Laboratorium, Berlin-Dahlem, Germany.

出版信息

EMBO J. 1993 Jan;12(1):213-22. doi: 10.1002/j.1460-2075.1993.tb05647.x.

Abstract

We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, p105 associates in the cytoplasm with p50 or p65. Through this assembly, p105 efficiently blocks nuclear transfer of either subunit. Moreover, the p105 protein inhibits DNA binding of dimeric NF-kappa B subunits in a similar, but not identical, manner to its isolated C-terminal domain, which contains an ankyrin-like repeat domain (ARD). The proto-oncogene product Bcl-3 also controls nuclear translocation of p50, but not of p65. Hence, p50 can be retained in the cytoplasm via at least three distinct interactions: through direct interactions either with its own precursor, with Bcl-3 or indirectly through I kappa B alpha or -beta when attached to p65. We discuss a function of p105 as a cytoplasmic assembly unit for homo- and heteromeric NF-kappa B complexes and of Bcl-3 as an I kappa B with novel subunit specificity.

摘要

我们研究了核因子κB前体p105与核因子κB亚基的相互作用。与IκB分子相似,p105在细胞质中与p50或p65缔合。通过这种组装,p105有效地阻止了任一亚基的核转运。此外,p105蛋白以与其分离的C末端结构域相似但不完全相同的方式抑制二聚体核因子κB亚基的DNA结合,该C末端结构域包含一个锚蛋白样重复结构域(ARD)。原癌基因产物Bcl-3也控制p50的核转运,但不控制p65的核转运。因此,p50可以通过至少三种不同的相互作用保留在细胞质中:通过与其自身前体直接相互作用、与Bcl-3直接相互作用,或当与p65结合时通过IκBα或IκBβ间接相互作用。我们讨论了p105作为同型和异型核因子κB复合物的细胞质组装单元的功能,以及Bcl-3作为具有新亚基特异性的IκB的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71de/413194/9492e2d707e0/emboj00073-0222-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验